210 related articles for article (PubMed ID: 16371368)
1. Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 signaling.
Yu WM; Daino H; Chen J; Bunting KD; Qu CK
J Biol Chem; 2006 Mar; 281(9):5426-34. PubMed ID: 16371368
[TBL] [Abstract][Full Text] [Related]
2. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
Yu WM; Hawley TS; Hawley RG; Qu CK
Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
[TBL] [Abstract][Full Text] [Related]
3. Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).
Wheadon H; Edmead C; Welham MJ
Biochem J; 2003 Nov; 376(Pt 1):147-57. PubMed ID: 12935294
[TBL] [Abstract][Full Text] [Related]
4. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor.
Chan RJ; Leedy MB; Munugalavadla V; Voorhorst CS; Li Y; Yu M; Kapur R
Blood; 2005 May; 105(9):3737-42. PubMed ID: 15644411
[TBL] [Abstract][Full Text] [Related]
5. Role of the docking protein Gab2 in beta(1)-integrin signaling pathway-mediated hematopoietic cell adhesion and migration.
Yu WM; Hawley TS; Hawley RG; Qu CK
Blood; 2002 Apr; 99(7):2351-9. PubMed ID: 11895767
[TBL] [Abstract][Full Text] [Related]
6. A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival.
Chen J; Yu WM; Bunting KD; Qu CK
Oncogene; 2004 Apr; 23(20):3659-69. PubMed ID: 15116097
[TBL] [Abstract][Full Text] [Related]
7. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
8. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.
Arnaud M; Mzali R; Gesbert F; Crouin C; Guenzi C; Vermot-Desroches C; Wijdenes J; Courtois G; Bernard O; Bertoglio J
Biochem J; 2004 Sep; 382(Pt 2):545-56. PubMed ID: 15170389
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation.
Arnaud M; Crouin C; Deon C; Loyaux D; Bertoglio J
J Immunol; 2004 Sep; 173(6):3962-71. PubMed ID: 15356145
[TBL] [Abstract][Full Text] [Related]
11. SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses.
Yang W; Tabrizi M; Berrada K; Yi T
Blood; 1998 May; 91(10):3746-55. PubMed ID: 9573011
[TBL] [Abstract][Full Text] [Related]
12. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
13. Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells.
Kapoor GS; Zhan Y; Johnson GR; O'Rourke DM
Mol Cell Biol; 2004 Jan; 24(2):823-36. PubMed ID: 14701753
[TBL] [Abstract][Full Text] [Related]
14. Noonan syndrome/leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN11) enhance cell migration and angiogenesis.
Wang S; Yu WM; Zhang W; McCrae KR; Neel BG; Qu CK
J Biol Chem; 2009 Jan; 284(2):913-20. PubMed ID: 19008228
[TBL] [Abstract][Full Text] [Related]
15. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.
Pathak MK; Yi T
J Immunol; 2001 Sep; 167(6):3391-7. PubMed ID: 11544330
[TBL] [Abstract][Full Text] [Related]
16. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
17. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
Paling NR; Welham MJ
Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells.
Schubbert S; Lieuw K; Rowe SL; Lee CM; Li X; Loh ML; Clapp DW; Shannon KM
Blood; 2005 Jul; 106(1):311-7. PubMed ID: 15761018
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel tyrosine phosphorylated 100-kDa protein that binds to SHP-2 and phosphatidylinositol 3'-kinase in myeloid cells.
Carlberg K; Rohrschneider LR
J Biol Chem; 1997 Jun; 272(25):15943-50. PubMed ID: 9188495
[TBL] [Abstract][Full Text] [Related]
20. Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells.
Zhang S; Mantel C; Broxmeyer HE
J Leukoc Biol; 1999 Mar; 65(3):372-80. PubMed ID: 10080542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
